Shirasaki, R, Simoes, R D M, Downey-Kopyscinski, S, Matthews, G, Hu, Y, Sheffer, M, Dhimolea, E, Dashevsky, O, Gandolfi, S, Hengeveld, P, Dempster, J, Meyers, R, Bryan, J, Dharia, N, McFarland, J, Sarkar, S, Bruggenthies, J, Tang, H, Bariteau, M, Aguirre, A, Borah, M, Sievers, Q, Ebert, B, Raja, J, Glassner, B J, Ott, C, Bradner, J, Kwiatkowski, N, Auclair, D, Levy, J, Poarch, H, Zhang, T, Laubach, J, Buckley, D, Schlossman, R, Groen, R, Fischer, E, Richardson, P G, Keats, J, Boise, L, Licht, J, Culhane, A, Gray, N, Hahn, W, Vazquez, F, Tsherniak, A & Mitsiades, C 2019, ' CRISPR studies identify genes preferentially essential for myeloma cells vs. other neoplasias: implications for future therapies selective against MM ', Clinical Lymphoma Myeloma and Leukemia, vol. 19, no. 10, pp. E48-E49 . Clinical Lymphoma Myeloma and Leukemia, 19(10), E48-E49. Cancer Media Group
Shirasaki, R, Simoes, R D M, Gandolfi, S, Matthews, G, Buckley, D, Raja, J, Sievers, Q, Bruggenthies, J, Dashevsky, O, Poarch, H, Tang, H, Bariteau, M, Sheffer, M, Hu, Y, Downey-Kopyscinski, S, Hengeveld, P, Glassner, B J, Dhimolea, E, Ott, C, Zhang, T, Kwiatkowski, N, Laubach, J, Schlossman, R, Culhane, A, Richardson, P G, Groen, R, Fischer, E, Vazquez, F, Tsherniak, A, Hahn, W, Levy, J, Auclair, D, Licht, J, Keats, J, Boise, L, Ebert, B, Bradner, J, Gray, N & Mitsiades, C 2019, ' Molecular markers of myeloma cell sensitivity vs. resistance to heterobifunctional degraders of oncoproteins: therapeutic implications ', Clinical Lymphoma Myeloma and Leukemia, vol. 19, no. 10, pp. E134-E134 . Clinical Lymphoma Myeloma and Leukemia, 19(10), E134-E134. Cancer Media Group